|
1
|
Arumugam P, M SM and Jayaseelan VP: A
novel m6A reader RBFOX2 expression is increased in oral squamous
cell carcinoma and promotes tumorigenesis. J Stomatol Oral
Maxillofac Surg. 102041:2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Murugesan D, Kannan B, As SG, Jayaseelan
VP and Arumugam P: Alteration of SERPINH1 is associated with
elevated expression in head and neck squamous cell carcinomas and
its clinicopathological significance. J Stomatol Oral Maxillofac
Surg. 125(101811)2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Miguelanez-Medran BC, Pozo-Kreilinger JJ,
Cebrian-Carretero JL, Martinez-Garcia MA and Lopez-Sanchez AF: Oral
squamous cell carcinoma of tongue: Histological risk assessment. A
pilot study. Med Oral Patol Oral Cir Bucal. 24:e603–e609.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sri S, Ramani P, Premkumar P, Ramshankar
V, Ramasubramanian A and Krishnan R: Prevalence of Human
Papillomavirus (HPV) 16 and 18 in oral malignant and potentially
malignant disorders: A polymerase chain reaction analysis-A
comparative study. Ann Maxillofac Surg. 11:6–11. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S,
Nice EC, Tang J and Huang C: Oral squamous cell carcinomas: state
of the field and emerging directions. Int J Oral Sci.
15(44)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shetty SS, Sharma M, Fonseca FP, Jayaram
P, Tanwar AS, Kabekkodu SP, Kapaettu S and Radhakrishnan R:
Signaling pathways promoting epithelial mesenchymal transition in
oral submucous fibrosis and oral squamous cell carcinoma. Jpn Dent
Sci Rev. 56:97–108. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu M, Song H, Xing Z, Lu G, Li J and Chen
D: Correlation between PTEN gene polymorphism and oral squamous
cell carcinoma. Oncol Lett. 18:1755–1760. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fusco N, Sajjadi E, Venetis K, Gaudioso G,
Lopez G, Corti C, Rocco EG, Criscitiello C, Malapelle U and
Invernizzi M: PTEN alterations and their role in cancer management:
Are we making headway on precision medicine? Genes (Basel).
11(719)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Travis G, McGowan EM, Simpson AM, Marsh DJ
and Nassif NT: PTEN, PTENP1, microRNAs, and ceRNA Networks:
Precision targeting in cancer therapeutics. Cancers (Basel).
15(4954)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Diener C, Keller A and Meese E: The
miRNA-target interactions: An underestimated intricacy. Nucleic
Acids Res. 52:1544–1557. 2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chakrabortty A, Patton DJ, Smith BF and
Agarwal P: miRNAs: Potential as biomarkers and therapeutic targets
for cancer. Genes (Basel). 14(1375)2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gu Y, Tang S, Wang Z, Cai L, Shen Y and
Zhou Y: Identification of key miRNAs and targeted genes involved in
the progression of oral squamous cell carcinoma. J Dent Sci.
17:666–676. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ahsan M, K P A, Usman P P AS and Sekar D:
Computational and expression analysis of microRNA-149-5p and its
target, interleukin-6, in chronic kidney disease. Biomed Res Ther.
10:6103–6109. 2023.
|
|
14
|
Suthagar P, Purayil ASUP, Parambath AK and
Sekar D: In silico identification and gene expression of
miR-148a-5p and IL-6 in hypothyroid patient blood samples. Biomed
Res Ther. 11:6379–6386. 2024.
|
|
15
|
Narayan RN, Parambath AK, Purayil ASUP and
Sekar D: microRNA-9-5p and its target nuclear factor kappa B are
differentially expressed in type-2 diabetes patients. Biomed Res
Ther. 11:6183–6190. 2024.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Oral cancer - the fight must go on against
all odds. Evid Based Dent. 23:4–5. 2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mesgari H, Esmaelian S, Nasiri K,
Ghasemzadeh S, Doroudgar P and Payandeh Z: Epigenetic regulation in
oral squamous cell carcinoma microenvironment: A comprehensive
review. Cancers (Basel). 15(5600)2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zedan AH, Osther PJS, Assenholt J, Madsen
JS and Hansen TF: Circulating miR-141 and miR-375 are associated
with treatment outcome in metastatic castration resistant prostate
cancer. Sci Rep. 10(227)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Guz M, Jeleniewicz W and Cybulski M:
Interactions between circRNAs and miR-141 in Cancer: From
pathogenesis to diagnosis and therapy. Int J Mol Sci.
24(11861)2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Khare S, Khare T, Ramanathan R and Ibdah
JA: Hepatocellular Carcinoma: The Role of MicroRNAs. Biomolecules.
12(645)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yang H, Liu Y, Chen L, Zhao J, Guo M, Zhao
X, Wen Z, He Z, Chen C and Xu L: MiRNA-based therapies for lung
cancer: Opportunities and challenges? Biomolecules.
13(877)2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bou Antoun N and Chioni AM: Dysregulated
signalling pathways driving anticancer drug resistance. Int J Mol
Sci. 24(12222)2023.PubMed/NCBI View Article : Google Scholar
|
